	销售和管理费用		日
Alaunos Therapeutics	USD 447K	138K	2026-03
Amgen	USD 1.72B	134M	2026-06
AstraZeneca	USD 5.8B	735M	2026-06
Baxter International	USD 735M	7M	2026-06
Biogen	USD 709.7M	155.4M	2026-06
Bioline Rx	USD 858K	257K	2026-03
Bristol-Myers Squibb	USD 1.83B	209M	2026-06
Celltrion	KRW 9.32B	3.39B	2026-03
Corcept Therapeutics	USD 156.9M	28.85M	2026-06
Cspc Pharmaceutical	CNY 1.87B	95.62M	2025-12
Curis	USD 2.96M	1.62M	2026-03
Deva Holding AS	TRY 462.26M	48.18M	2023-09
Dianthus Therapeutics	USD 12.47M	5.89M	2026-03
Divis Laboratories Ltd	INR 3.4B	10M	2025-06
Gilead Sciences	USD 1.52B	70M	2026-06
GlaxoSmithKline	GBP 2.19B	75M	2026-06
Incyte	USD 351.73M	23.64M	2026-06
Intrexon	USD 10.31M	41K	2024-06
Ionis Pharmaceuticals	USD 130.07M	20.92M	2026-06
J&J	USD 6.42B	381M	2026-06
Kangmei Pharma	CNY 237.06M	37.35M	2026-03
Karyopharm Therapeutics	USD 10.42M	861K	2026-03
Knight Therapeutics	CAD 35.45M	4.43M	2025-12
Laboratorios Farma	EUR 35.32M	2.75M	2025-06
Malin Corporation	EUR 1.1M	400K	2024-12
Medical Developments International	AUD 2.84M	4.19M	2025-12
Merck	USD 2.89B	219M	2026-06
Neuren Pharmaceuticals	AUD 3.74M	2.5M	2025-12
Novartis	USD 3.24B	101M	2026-06
Organigram Holdings	CAD 22.01M	14.28M	2026-03
Ovoca Bio	EUR 617K	15K	2025-12
Pfizer	USD 3.41B	496M	2026-06
Pharma Mar	EUR 17.12M	1.82M	2026-06
PTC Therapeutics	USD 73.89M	13.31M	2026-03
Qiagen NV	USD 142.33M	60K	2026-06
Regeneron Pharmaceuticals	USD 662.1M	14.4M	2026-06
Roche Holding	CHF 6.37B	908M	2026-06
Sangamo BioSciences	USD 9.64M	1.83M	2024-06
Sartorius	EUR 221.3M	0	2026-06
Sino Biopharmaceutical	CNY 7.54B	2.23B	2025-06
TG Therapeutics	USD 62.32M	10.82M	2026-06
Tilray	USD 24.85M	1.7M	2025-09
Verastem	USD 22.3M	2.14M	2026-03
Zealand Pharma A/S	104M	12.19M	2026-03
Zz Pientze Pharmaceu	CNY 214.31M	42.4M	2026-03